{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:48:08Z","timestamp":1782028088805,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jacep.2026.01.010","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:06:00Z","timestamp":1772139960000},"page":"1131-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Thibaut","family":"Moulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Zaroui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ramoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Rouffiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounira","family":"Kharoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Djouadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soulef","family":"Guendouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ouazana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnault","family":"Galat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Gounot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Belhadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarvinder S.","family":"Dhanjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Le Corvoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Audureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Teiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Oghina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lellouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jacep.2026.01.010_bib1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL Cardiac amyloidosis","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2026.01.010_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13506129.2021.2013193","article-title":"Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival","volume":"29","author":"Kharoubi","year":"2022","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.jacep.2026.01.010_bib3","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/bjh.17399","article-title":"Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities?","volume":"193","author":"Zampieri","year":"2021","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.jacep.2026.01.010_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.01.010_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.jacep.2026.01.010_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"10.1016\/j.jacep.2026.01.010_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.jacep.2026.01.010_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.jacep.2026.01.010_bib9","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/europace\/euaa094","article-title":"Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator","volume":"22","author":"Kim","year":"2020","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.jacep.2026.01.010_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jjcc.2023.02.009","article-title":"Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis","volume":"81","author":"Bukhari","year":"2023","journal-title":"J Cardiol"},{"issue":"40","key":"10.1016\/j.jacep.2026.01.010_bib11","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.jacep.2026.01.010_bib12","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2026.01.010_bib13","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/ehf2.14671","article-title":"Prognostic mortality factors in advanced light chain cardiac amyloidosis: a prospective cohort study","volume":"11","author":"Zaroui","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"15","key":"10.1016\/j.jacep.2026.01.010_bib14","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jacep.2026.01.010_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae063","article-title":"Prognostic implications of premature ventricular contractions and non-sustained ventricular tachycardia in light-chain cardiac amyloidosis","volume":"26","author":"Chen","year":"2024","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.jacep.2026.01.010_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF","volume":"10","author":"Barros-Gomes","year":"2017","journal-title":"JACC Cardiovasc Img"},{"issue":"7","key":"10.1016\/j.jacep.2026.01.010_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/europace\/euaa367","article-title":"EHRA\/HRS\/APHRS\/LAHRS expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators","volume":"23","author":"Burri","year":"2021","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.jacep.2026.01.010_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/europace\/euv411","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"18","author":"Wilkoff","year":"2016","journal-title":"Europace"},{"issue":"9","key":"10.1016\/j.jacep.2026.01.010_bib19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/europace\/euz065","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"21","author":"Stiles","year":"2019","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.jacep.2026.01.010_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2026.01.010_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic features and rhythm disorders in cardiac amyloidosis","volume":"34","author":"Martini","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.jacep.2026.01.010_bib22","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.ijcard.2012.05.097","article-title":"Prognostic value of fragmented QRS in cardiac AL amyloidosis","volume":"167","author":"Perlini","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2026.01.010_bib23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/10428194.2020.1850717","article-title":"Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment","volume":"62","author":"Gounot","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.jacep.2026.01.010_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257189","article-title":"Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement","volume":"16","author":"B\u00e9zard","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jacep.2026.01.010_bib25","first-page":"65","article-title":"Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death","volume":"20","author":"Amara","year":"2018","journal-title":"Europace"},{"issue":"9","key":"10.1016\/j.jacep.2026.01.010_bib26","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"10.1016\/j.jacep.2026.01.010_bib27","doi-asserted-by":"crossref","first-page":"19813","DOI":"10.1074\/jbc.M116.736736","article-title":"Cell damage in light chain amyloidosis: fibril internalization, toxicity and cell-mediated seeding","volume":"291","author":"Marin-Argany","year":"2016","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jacep.2026.01.010_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2024.2373748","article-title":"Internalisation of immunoglobulin light chains by cardiomyocytes in AL amyloidosis: what can biopsies tell us?","volume":"31","author":"B\u00e9zard","year":"2024","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.jacep.2026.01.010_bib29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00380-015-0658-0","article-title":"Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia","volume":"31","author":"Hashimura","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacep.2026.01.010_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.02.004","article-title":"Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis","volume":"76","author":"Le Bras","year":"2017","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.jacep.2026.01.010_bib31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jcmg.2021.01.016","article-title":"Prognostic utility of echocardiographic atrial and ventricular strain imaging in patients with cardiac amyloidosis","volume":"14","author":"Huntjens","year":"2021","journal-title":"JACC Cardiovasc Img"},{"issue":"4","key":"10.1016\/j.jacep.2026.01.010_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","article-title":"Prognostic significance of strain Doppler imaging in light-chain amyloidosis","volume":"3","author":"Koyama","year":"2010","journal-title":"JACC Cardiovasc Img"},{"issue":"18","key":"10.1016\/j.jacep.2026.01.010_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012097","article-title":"Noninvasive mapping of the electrophysiological substrate in cardiac amyloidosis and its relationship to structural abnormalities","volume":"8","author":"Orini","year":"2019","journal-title":"J Am Heart Assoc"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:28:53Z","timestamp":1782026933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X26000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2405500X26000150"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2026.01.010","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2026.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}